Black Diamond Therapeutic Analyst Ratings
Buy Rating Affirmed for Black Diamond Therapeutics Amid Strong Financials and Promising Clinical Trials
Black Diamond Therapeutics (BDTX) Gets a Buy From Piper Sandler
Black Diamond Therapeutic Analyst Ratings
Black Diamond Therapeutic Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Black Diamond Therapeutics (BDTX) and I-MAB (IMAB)
Black Diamond Therapeutic Analyst Ratings
Black Diamond Therapeutics (BDTX) Receives a Buy From TD Cowen
Analysts Are Bullish on These Healthcare Stocks: Black Diamond Therapeutics (BDTX), Enanta Pharmaceuticals (ENTA)
Analysts' Top Healthcare Picks: Black Diamond Therapeutics (BDTX), Amylyx Pharmaceuticals Inc (AMLX)
Black Diamond Therapeutic Analyst Ratings
TD Cowen Sticks to Its Buy Rating for Black Diamond Therapeutics (BDTX)
Black Diamond Therapeutics (BDTX) Receives a Buy From Piper Sandler
Wedbush Reiterates Outperform on Black Diamond Therapeutic, Maintains $10 Price Target
Black Diamond Therapeutic Analyst Ratings
Piper Sandler Keeps Their Buy Rating on Black Diamond Therapeutics (BDTX)
Piper Sandler Initiates Coverage On Black Diamond Therapeutic With Overweight Rating, Announces Price Target of $11
Black Diamond Therapeutic Analyst Ratings
Stifel Upgrades Black Diamond Therapeutic to Buy, Raises Price Target to $10
What 4 Analyst Ratings Have To Say About Black Diamond Therapeutic
No Data